US Patent 11111494 Compositions for modulating Ataxin 2 expression
Patent 11111494 was granted and assigned to Ionis Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 17, 2019
Date of Patent
September 7, 2021
Patent Applicant
Patent Application Number
20190417
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11111494 Compositions for modulating Ataxin 2 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.